(Q28192380)

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-3204-6

Anticardiolipin antibodies are an independent risk factor for ischemic stroke.

21 January 2018

1 reference

12 December 2020

Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies

1 reference

12 December 2020

Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS)

1 reference

12 December 2020

Antiphospholipid antibodies in an in vivo thrombosis model in mice

1 reference

12 December 2020

Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study

1 reference

12 December 2020

Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus

1 reference

12 December 2020

Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report

1 reference

12 December 2020

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

1 reference

12 December 2020

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

1 reference

12 December 2020

Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus

1 reference

12 December 2020

Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo

1 reference

12 December 2020

Origin of antiphospholipid antibodies: induction of aPL by viral peptides

1 reference

12 December 2020

Coronary and valvular syndromes and antiphospholipid antibodies

1 reference

12 December 2020

Cerebral venous thrombosis and anticardiolipin antibodies

1 reference

12 December 2020

The frequency of phospholipid antibodies in an unselected stroke population

1 reference

12 December 2020

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

12 December 2020

The role of antiphospholipid antibodies in stroke.

1 reference

12 December 2020

Anticardiolipin antibodies in an unselected stroke population

1 reference

12 December 2020

MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension

1 reference

12 December 2020

Antiphospholipid antibodies and stroke in young women

1 reference

12 December 2020

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

1 reference

12 December 2020

Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation

1 reference

12 December 2020

Detection of cerebral microemboli in APS--introducing a novel investigation method and implications of analogies with carotid artery disease

1 reference

12 December 2020

Antiphospholipid antibodies and cerebral ischemia in young people

1 reference

12 December 2020

Anticardiolipin antibodies and their associations with cerebrovascular risk factors

1 reference

12 December 2020

Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells

1 reference

12 December 2020

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

1 reference

12 December 2020

Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome

1 reference

12 December 2020

Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group

1 reference

12 December 2020

Familial antiphospholipid syndrome and HLA-DRB gene associations

1 reference

12 December 2020

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis

1 reference

12 December 2020

Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study

1 reference

12 December 2020

Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.

1 reference

12 December 2020

GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.

1 reference

12 December 2020

Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype

1 reference

12 December 2020

Antiphospholipid syndrome: multiple mechanisms

1 reference

12 December 2020

Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease

1 reference

12 December 2020

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

12 December 2020

A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis

1 reference

12 December 2020

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

12 December 2020

A family study of the antiphospholipid syndrome associated with other autoimmune diseases

1 reference

12 December 2020

Thrombotic endocarditis and lupus anticoagulant. A pathogenetic possibility for idiopathic 'rheumatic type' valvular heart disease

1 reference

12 December 2020

Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies

1 reference

12 December 2020

Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients

1 reference

12 December 2020

Anti-cardiolipin antibodies in ischaemic heart disease.

1 reference

12 December 2020

MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus

1 reference

12 December 2020

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

1 reference

12 December 2020

Antiphosphatidyl serine antibodies are independently associated with ischemic stroke

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Cerebral venous thrombosis

1 reference

12 December 2020

Familial antiphospholipid antibody syndrome: Criteria for disease and evidence for autosomal dominant inheritance

1 reference

12 December 2020

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

1 reference

12 December 2020

Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects

1 reference

12 December 2020

Clinicopathologic correlations of antiphospholipid antibodies. An autopsy study

1 reference

12 December 2020

Antiphospholipid antibodies lead to increased risk in cardiovascular surgery

1 reference

12 December 2020

The association of antiphospholipid antibodies with ischaemic stroke and myocardial infarction in young and their correlation: a preliminary study

1 reference

12 December 2020

Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects

1 reference

12 December 2020

Beta 2 glycoprotein I--function in health and disease

1 reference

12 December 2020

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

12 December 2020

Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results

1 reference

12 December 2020

Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group

1 reference

12 December 2020

Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides

1 reference

12 December 2020

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

12 December 2020